Compare EME & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EME | IDXX |
|---|---|---|
| Founded | 1987 | 1983 |
| Country | United States | United States |
| Employees | 25000 | N/A |
| Industry | Engineering & Construction | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.7B | 45.4B |
| IPO Year | 1994 | 1996 |
| Metric | EME | IDXX |
|---|---|---|
| Price | $804.93 | $558.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $831.67 | $721.67 |
| AVG Volume (30 Days) | 440.9K | ★ 552.2K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.19% | N/A |
| EPS Growth | ★ 30.99 | 22.59 |
| EPS | ★ 15.89 | 3.47 |
| Revenue | ★ $16,986,422,000.00 | $4,303,702,000.00 |
| Revenue This Year | $7.85 | $10.88 |
| Revenue Next Year | $7.05 | $8.59 |
| P/E Ratio | ★ $98.32 | $164.20 |
| Revenue Growth | ★ 16.62 | 10.42 |
| 52 Week Low | $564.92 | $518.55 |
| 52 Week High | $951.96 | $769.98 |
| Indicator | EME | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 27.21 | 55.49 |
| Support Level | $629.54 | $567.62 |
| Resistance Level | $777.25 | $583.93 |
| Average True Range (ATR) | 25.72 | 16.39 |
| MACD | -5.66 | 1.13 |
| Stochastic Oscillator | 3.00 | 75.32 |
EMCOR Group Inc is a specialty contractor in the United States and a provider of electrical and mechanical construction and facilities services, building services, and industrial services. Its services are provided to a broad range of commercial, technology, manufacturing, industrial, healthcare, utility, and institutional customers through approximately 100 operating subsidiaries. The company's operating subsidiaries are organized into reportable segments: United States mechanical construction and facilities services, which derives key revenue; United States electrical construction and facilities services; United States building services; United States industrial services; and United Kingdom building services. Geographically, its key revenue is derived from the United States.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.